BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 17027827)

  • 1. Serum uric acid is a determinant of metabolic syndrome in a population-based study.
    Onat A; Uyarel H; Hergenç G; Karabulut A; Albayrak S; Sari I; Yazici M; Keleş I
    Am J Hypertens; 2006 Oct; 19(10):1055-62. PubMed ID: 17027827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum gamma glutamyltransferase as a marker of metabolic syndrome and coronary disease likelihood in nondiabetic middle-aged and elderly adults.
    Onat A; Hergenç G; Karabulut A; Türkmen S; Doğan Y; Uyarel H; Can G; Sansoy V
    Prev Med; 2006 Aug; 43(2):136-9. PubMed ID: 16714057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-sectional study of complement C3 as a coronary risk factor among men and women.
    Onat A; Uzunlar B; Hergenç G; Yazici M; Sari I; Uyarel H; Can G; Sansoy V
    Clin Sci (Lond); 2005 Feb; 108(2):129-35. PubMed ID: 15487975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum total and high-density lipoprotein phospholipid levels in a population-based study and relationship to risk of metabolic syndrome and coronary disease.
    Hergenç G; Onat A; Sari I; Yazici M; Eryonucu B; Can G
    Angiology; 2008; 59(1):26-35. PubMed ID: 18319219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation.
    Onat A; Hergenç G; Türkmen S; Yazici M; Sari I; Can G
    Metabolism; 2006 Apr; 55(4):445-52. PubMed ID: 16546474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of abdominal obesity and high susceptibility of cardiometabolic risk to its increments among Turkish women: a prospective population-based study.
    Onat A; Sari I; Hergenç G; Yazici M; Uyarel H; Can G; Sansoy V
    Metabolism; 2007 Mar; 56(3):348-56. PubMed ID: 17292723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis.
    Coutinho Tde A; Turner ST; Peyser PA; Bielak LF; Sheedy PF; Kullo IJ
    Am J Hypertens; 2007 Jan; 20(1):83-9. PubMed ID: 17198917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma triglycerides, an independent predictor of cardiovascular disease in men: a prospective study based on a population with prevalent metabolic syndrome.
    Onat A; Sari I; Yazici M; Can G; Hergenç G; Avci GS
    Int J Cardiol; 2006 Mar; 108(1):89-95. PubMed ID: 16085325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk.
    Onat A; Can G; Hergenç G
    Metabolism; 2008 Feb; 57(2):207-14. PubMed ID: 18191050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey.
    Onat A; Hergenç G; Uyarel H; Can G; Ozhan H
    Anadolu Kardiyol Derg; 2006 Dec; 6(4):314-21. PubMed ID: 17162275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum sex hormone-binding globulin, a determinant of cardiometabolic disorders independent of abdominal obesity and insulin resistance in elderly men and women.
    Onat A; Hergenç G; Karabulut A; Albayrak S; Can G; Kaya Z
    Metabolism; 2007 Oct; 56(10):1356-62. PubMed ID: 17884445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein(a) is associated with coronary heart disease independent of metabolic syndrome.
    Onat A; Hergenç G; Ozhan H; Kaya Z; Bulur S; Ayhan E; Can G
    Coron Artery Dis; 2008 May; 19(3):125-31. PubMed ID: 18418227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population.
    Onat A; Hergenç G; Can G; Kaya Z; Yüksel H
    Metabolism; 2010 May; 59(5):628-34. PubMed ID: 19913840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between serum uric acid and the Adult Treatment Panel III-defined metabolic syndrome: results from a single hospital database.
    Rho YH; Woo JH; Choi SJ; Lee YH; Ji JD; Song GG
    Metabolism; 2008 Jan; 57(1):71-6. PubMed ID: 18078861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome.
    Santos AC; Lopes C; Guimarães JT; Barros H
    Int J Obes (Lond); 2005 Dec; 29(12):1452-6. PubMed ID: 16077717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation.
    Onat A; Can G; Hergenç G; Yazici M; Karabulut A; Albayrak S
    Int J Obes (Lond); 2007 Jul; 31(7):1119-25. PubMed ID: 17299378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-dependent associations of leptin with metabolic syndrome-related variables: the Stanislas study.
    Samara A; Herbeth B; Aubert R; Berrahmoune H; Fumeron F; Siest G; Visvikis-Siest S
    Obesity (Silver Spring); 2010 Jan; 18(1):196-201. PubMed ID: 19444226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measures of obesity and metabolic syndrome in Indian Americans in northern California.
    Misra KB; Endemann SW; Ayer M
    Ethn Dis; 2006; 16(2):331-7. PubMed ID: 17682232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum folate is associated with coronary heart disease independently of homocysteine in Turkish men.
    Onat A; Hergenç G; Küçükdurmaz Z; Can G; Ayhan E; Bulur S
    Clin Nutr; 2008 Oct; 27(5):732-9. PubMed ID: 18694616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Waist circumference adds to the variance in plasma C-reactive protein levels in elderly patients with metabolic syndrome.
    Dupuy AM; Jaussent I; Lacroux A; Durant R; Cristol JP; Delcourt C
    Gerontology; 2007; 53(6):329-39. PubMed ID: 17551260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.